Source: iQoncept / Shutterstock
Spruce Biosciences (NASDAQ:SPRB) just reported results for the first quarter of 2024.
- Spruce Biosciences reported earnings per share of -28 cents. This was above the analyst estimate for EPS of -29 cents.
- The company reported revenue of $2.02 million.
- This was 74.14% better than the analyst estimate for revenue of $1.16 million.
Article printed from InvestorPlace Media, https://investorplace.com/earning-results/2024/05/sprb-stock-earnings-spruce-biosciences-for-q1-of-2024/.
©2024 InvestorPlace Media, LLC









